Literature DB >> 9430858

Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study.

P Jungers1, Z A Massy, T Nguyen Khoa, C Fumeron, M Labrunie, B Lacour, B Descamps-Latscha, N K Man.   

Abstract

BACKGROUND: Accelerated atherosclerosis resulting in an abnormally high incidence of coronary and cerebrovascular occlusive accidents has been repeatedly reported in dialysis patients, but incidence and risk factors of such complications in chronic renal failure (CRF) predialysis patients are debated.
METHODS: We prospectively assessed the incidence of first myocardial and cerebral infarction episodes in a cohort of 147 CRF patients (99 male) followed from January 1985 to December 1994. Relevant clinical and laboratory risk factors for atherogenesis were determined at yearly intervals. They included blood pressure, smoking, blood lipids, fibrinogen, and homocysteine which were compared in patients with (CVA+) or without (CVA-) occurrence of cardiovascular (CV) atherosclerotic accidents.
RESULTS: Incidence of CV accidents was nearly three times higher in CRF patients than in the French general population in both genders. In particular, incidence of myocardial infarction in male patients aged 45-55, 55-65 and > 65 years was 7.6, 18.2, and 27.8/1000 patient-years, respectively, compared to 3.4, 8.9, and 10.4/1000 subject-years in the general population. Although age and degree of renal failure at onset of CV events or at end of follow-up did not differ between CVA+ and CVA- groups, cigarette smoking (24.5 [SD 24.3] vs 8.2 [14.7] pack-years, P < 0.0001) and systolic blood pressure (159 [19] vs 148 [19] mmHg, P < 0.001) were markedly higher in CVA+ patients. Similarly, mean plasma HDL-cholesterol was lower, whereas LDL-cholesterol, triglycerides, apoB, Lp(a), fibrinogen, and homocysteine levels all were significantly higher in CVA+ than in CVA- patients. Multivariate Cox analysis identified cigarette smoking, systolic pressure, HDL cholesterol, and fibrinogen as independent risk factors for developing CV accidents.
CONCLUSIONS: Incidence of atherosclerotic CV complications is abnormally high in predialysis CRF patients, suggesting that the uraemic state per se is associated with atherogenesis. As several of the identified clinical and metabolic risk factors for such accidents are potentially remediable by specific therapeutic interventions, prophylactic measures should be initiated long before start of renal replacement therapy.

Entities:  

Mesh:

Year:  1997        PMID: 9430858     DOI: 10.1093/ndt/12.12.2597

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  44 in total

Review 1.  Epidemiology, diagnosis, and management of cardiac disease in chronic renal disease.

Authors:  M J Sarnak; A S Levey
Journal:  J Thromb Thrombolysis       Date:  2000-10       Impact factor: 2.300

2.  Glomerular filtration rate is related to severity of obstructive coronary artery disease in patients undergoing coronary angiography.

Authors:  Gholamreza Davoodi; Samira Mehrabi Pari; Mehrnaz Rezvanfard; Mahmood Sheikh Fathollahi; Manouchehr Amini; Elham Hakki; Ali Kazemisaeid; Ahmad Yaminisharif
Journal:  Int Urol Nephrol       Date:  2011-10-16       Impact factor: 2.370

Review 3.  Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials.

Authors:  Giovanni F M Strippoli; Sankar D Navaneethan; David W Johnson; Vlado Perkovic; Fabio Pellegrini; Antonio Nicolucci; Jonathan C Craig
Journal:  BMJ       Date:  2008-02-25

4.  Effects of exercise in renal transplant recipients.

Authors:  Giulio Romano; Eric Lorenzon; Domenico Montanaro
Journal:  World J Transplant       Date:  2012-08-24

5.  Evidence-based practice guideline for the treatment of CKD.

Authors: 
Journal:  Clin Exp Nephrol       Date:  2009-12       Impact factor: 2.801

6.  Healthy lifestyle and risk of kidney disease progression, atherosclerotic events, and death in CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.

Authors:  Ana C Ricardo; Cheryl A Anderson; Wei Yang; Xiaoming Zhang; Michael J Fischer; Laura M Dember; Jeffrey C Fink; Anne Frydrych; Nancy G Jensvold; Eva Lustigova; Lisa C Nessel; Anna C Porter; Mahboob Rahman; Julie A Wright Nunes; Martha L Daviglus; James P Lash
Journal:  Am J Kidney Dis       Date:  2014-11-20       Impact factor: 8.860

Review 7.  Consensus statement on management of dyslipidemia in Indian subjects.

Authors:  K Sarat Chandra; Manish Bansal; Tiny Nair; S S Iyengar; Rajeev Gupta; Subhash C Manchanda; P P Mohanan; V Dayasagar Rao; C N Manjunath; J P S Sawhney; Nakul Sinha; A K Pancholia; Sundeep Mishra; Ravi R Kasliwal; Saumitra Kumar; Unni Krishnan; Sanjay Kalra; Anoop Misra; Usha Shrivastava; Seema Gulati
Journal:  Indian Heart J       Date:  2014-12-24

Review 8.  How to balance risks and benefits in the management of CKD patients with coronary artery disease.

Authors:  Giancarlo Marenzi; Nicola Cosentino; Carlo Guastoni
Journal:  J Nephrol       Date:  2015-02-25       Impact factor: 3.902

9.  Abnormalities of endothelial function in patients with predialysis renal failure.

Authors:  J Thambyrajah; M J Landray; F J McGlynn; H J Jones; D C Wheeler; J N Townend
Journal:  Heart       Date:  2000-02       Impact factor: 5.994

10.  Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study.

Authors:  Christopher B Brady; J Michael Gaziano; Roberta A Cxypoliski; Peter D Guarino; James S Kaufman; Stuart R Warren; Pamela Hartigan; David S Goldfarb; Rex L Jamison
Journal:  Am J Kidney Dis       Date:  2009-07-23       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.